Company: DAWN
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001140361-25-013462
Chunk: 48

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 48
---
| Executive          |     |   Salary |     | Target Bonus  
 (% of Salary) |     | Target Bonus |
| Jeremy Bender      |     | $680,000 |     | 60%           |     |     $408,000 |
| Charles York, II   |     | $541,000 |     | 45%           |     |     $243,000 |
| Samuel Blackman(1) |     | $527,000 |     | 45%           |     |     $237,000 |
| Adam Dubow         |     | $455,000 |     | 40%           |     |     $182,000 |

| (1) | Dr. Blackman retired from the Company effective January 3, 2025 and is no longer considered an executive officer of the Company. |

Final payouts for each NEO are determined by multiplying the NEO’s target bonus by 100% of the company performance multiplier fixed by the Compensation Committee at the end of the year based on the Company’s achievement in each of the four categories of objectives with discretionary adjustment based on the NEO’s individual performance. Performance Metrics and Results Corporate performance goals include stretch goals to incentivize and motivate accelerated achievement of certain objectives. Recognition of stretch achievements ties executive compensation to Company performance, consistent with our pay for performance compensation philosophy. In a series of meetings in late November and early December 2024, our Compensation Committee and our board of directors reviewed our 2024 corporate goals, taking into account the weighting for each goal and its determination of an achievement rating with respect to each such goal, as well as additional organizational accomplishments in 2024, and approved, based on the aggregate performance level pursuant to such factors, a company performance multiplier of 123% with respect to each executive’s bonus. Final Annual Incentive Awards In recognition of their efforts towards our successful achievement of such goals and milestones, the Compensation Committee approved awarding Mr. Bender, Mr. York, Dr. Blackman and Mr. Dubow their respective individual bonuses for 2024 at approximately 123% of each executive’s individual bonus opportunity, taking into account the

38

TABLE OF CONTENTS

determination that we achieved our corporate goals at the 123% level and the individual performance goals at 100% based on the NEO’s individual performance as determined by the CEO (other than himself) and Compensation Committee (for CEO). The 2024 annual bonus payments for the NEOs, which were paid in February 2025, are